DEA Archived Press Releases

Press Releases before January 20, 2025
10 Results - Showing 1 to 10
PRESS RELEASE

South Florida Man Pleads Guilty to Participating in a Conspiracy to Distribute Protonitazene from China

MIAMI – A south Florida defendant pled guilty to participating in a conspiracy to possess with intent to distribute a synthetic opioid, protonitazene. Will Catis, Sr. (Catis), 42, of Deerfield Beach, pled guilty before U.S. District Judge Raag Singhal. According to the agreed upon factual proffer, on April 12, 2022...
PRESS RELEASE

South Florida Doctor Sentenced to Prison for Unlawfully Dispensing Narcotics

MIAMI – Dr. Ronald Lubetsky was sentenced this week to five (5) years in prison by U.S. District Judge Donald M. Middlebrooks for unlawfully dispensing narcotics—specifically oxycodone and morphine. Lubetsky was convicted at trial in November on seven counts of unlawfully dispensing narcotics. Trial evidence showed that law enforcement learned...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

MIAMI – On Sunday, August 21, the Drug Enforcement Administration (DEA) will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several organizations...
PRESS RELEASE

DEA Miami Field Division Warns of Alarming Increase in Suspected Fentanyl-Related Overdoses in Florida

MIAMI - Today, the Drug Enforcement Administration (DEA) Miami Field Division has issued a Public Safety Alert to warn Florida communities of the increase of mass-overdose events across the state suspected to be related to drug supplies laced with a synthetic opioid. While law enforcement agencies continue to investigate these...
PRESS RELEASE

DEA Rolls Out Operation Engage

MIAMI - Today, the United States Drug Enforcement Administration launched a new comprehensive law enforcement and prevention initiative aimed at reducing drug use, abuse, and overdose deaths. “Operation Engage” allows participating field divisions to focus on the biggest drug threat and resulting violence in their respective geographic areas. The initiative...
PRESS RELEASE

Husband and wife sentenced in connection with pain clinic pill mill scheme

BIRMINGHAM, Ala. – A federal judge today sentenced a Springville couple involved in a St. Clair County pill mill scheme, announced Drug Enforcement Administration Special Agent in Charge of the New Orleans Division Brad L. Byerley, U.S. Attorney Jay E. Town, and IRS-Criminal Investigations Atlanta Field Office Special Agent in...
PRESS RELEASE

DEA announces results in massive statewide opioid sweep

MIAMI – DEA Miami Division Special Agent in Charge Adolphus P. Wright today announced the results of a three-day, statewide enforcement operation targeting opioids. The DEA-led surge brought together hundreds of federal, state and local law enforcement agencies throughout Florida. The operation targeted all levels of opioid distributors in the...
PRESS RELEASE

DEA announces results of major state-wide enforcement operation

LITTLE ROCK, Ark. – The Drug Enforcement Administration, in conjunction with federal and state prosecutors, announced today an unprecedented enforcement action spanning across the state of Arkansas in a combined effort to reverse the horrible effects on communities produced by violent drug traffickers. As part of this effort, dubbed Operation...
PRESS RELEASE

Montgomery “pill mill” doctor receives over 12 year sentence for drug distribution, health care fraud, and money laundering offenses

MONTGOMERY, Ala. – Dr. Gilberto Sanchez, 56, of Montgomery, Alabama, was sentenced to serve 12 years and 1 month in prison for prescribing unnecessary controlled substances to his patients, committing health care fraud, and laundering money, announced Drug Enforcement Administration Assistant Special Agent in Charge Bret Hamilton and United States...
PRESS RELEASE

CVS Pharmacy pays one million penalty in settlement with DOJ for violations of the Controlled Substances Act

BIRMINGHAM, Ala. – The Department of Justice has reached an agreement with CVS Pharmacy, Inc. to resolve violations of the federal Controlled Substances Act and its implementing regulations at CVS Pharmacy locations throughout the Northern District of Alabama, announced DEA Special Agent in Charge Stephen G. Azzam and U.S. Attorney...